Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
(Q31019088)
scientific article
scientific article
Language:
Current Data About
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.